Bidco to acquire biopharmaceutical services company Ergomed
Summary
Eden AcquisitionCo (Bidco) has signed an agreement to acquire British biopharmaceutical services company Ergomed in a deal valued at around £703.1m ($884.79m). Ergomed is a differentiated platform engaged in the outsourced pharma services sector with a strong track record in the contract research organisation (CRO) and pharmacovigilance (PV) spaces. Through this acquisition, Permira will provide support to Ergomed for its next phase of growth by investing in the commercial expansion and technological transformation of the business. Permira will also provide additional capital for undertaking transformational mergers and acquisitions (M&A). It also brings with it opportunities to access their operational expertise, global network and capital.